A discussion of medical cannabis and the regulatory frameworks and market forces which impact its availability in Australia and elsewhere. Nick Lintzeris is a director of drug and alcohol services in Sydney, a conjoint professor with the Faculty of Medicine at the University of Sydney, and a chief investigator for the newly established Australian Centre for Cannabinoid and Clinical Research Excellence.